We are live on ! Find out more
CRIG

Charter Research & Investment Group Portfolio holdings

AUM $150M
1-Year Est. Return 28.05%
This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+28.05%
3 Year Est. Return
+71.14%
5 Year Est. Return
+100.32%
10 Year Est. Return
AUM
$144M
AUM Growth
+$10.5M
Cap. Flow
-$1.46M
Cap. Flow %
-1.01%
Top 10 Hldgs %
46.1%
Holding
85
New
2
Increased
13
Reduced
29
Closed
2

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$607K
2
AAPL icon
Apple
AAPL
+$222K
3
HUBB icon
Hubbell
HUBB
+$208K
4
TXN icon
Texas Instruments
TXN
+$203K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$151K

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Communication Services 16.49%
3 Consumer Staples 11.03%
4 Healthcare 10.02%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
76
ConocoPhillips
COP
$148B
$241K 0.17%
2,545
VEU icon
77
Vanguard FTSE All-World ex-US ETF
VEU
$69.9B
$239K 0.17%
3,350
WTRG icon
78
Essential Utilities
WTRG
$11.3B
$237K 0.16%
5,930
EXR icon
79
Extra Space Storage
EXR
$31B
$227K 0.16%
1,610
WM icon
80
Waste Management
WM
$90.6B
$223K 0.15%
1,010
STZ icon
81
Constellation Brands
STZ
$22.8B
$221K 0.15%
1,641
-80
-5% -$12.7K
DUK icon
82
Duke Energy
DUK
$94.5B
$220K 0.15%
1,781
CB icon
83
Chubb
CB
$134B
$216K 0.15%
765
-55
-7% -$15.1K
HUBB icon
84
Hubbell
HUBB
$26.7B
-510
Closed -$208K
TXN icon
85
Texas Instruments
TXN
$256B
-976
Closed -$203K

Similar funds

Charter Research & Investment Group's Q3 2025 Portfolio in Review

As of Q3 2025, Charter Research & Investment Group held 85 positions worth $144M, up 7.8% from $134M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.7%. Charter Research & Investment Group opened 2 new positions and exited 2, leaving the 85-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Charter Research & Investment Group's largest Q3 2025 buy was Alnylam Pharmaceuticals: 585 shares worth $267K.
  • Charter Research & Investment Group added most to Invesco S&P 500 Equal Weight ETF in Q3 2025, an estimated $142K increase.
  • Charter Research & Investment Group's biggest Q3 2025 reduction was Merck, cutting an estimated $607K.
  • Charter Research & Investment Group fully exited Hubbell in Q3 2025, selling an estimated $208K.
  • Charter Research & Investment Group's ten largest holdings make up 46% of its $144M portfolio in Q3 2025.
  • Charter Research & Investment Group opened 2 new positions and closed 2 in Q3 2025.
  • Charter Research & Investment Group's portfolio value rose 7.8% quarter-over-quarter to $144M.

Based on Charter Research & Investment Group's 13F filing for Q3 2025, filed 12 Nov 2025.